Aaron J. Weiss, MD PhD

Cardiothoracic Surgeon and Scientist, Cardiac Transplantation and Mechanical Circulatory Support (opinions are my own), Northwell Health

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Excited to share our experience with Impella in managing patients presenting with a post-MI VSR. Study highlights new insights in device use, hemodynamic benefits and improved outcomes within the scope of a shifting treatment paradigm. #jtcvs
https://t.co/6YWCn8UcfP

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Safe and effective mobilization of patients with cardiogenic shock receiving tMCS can be accomplished. Appropriate patient selection, tailored device management, and dynamic multidisciplinary approaches to mobilization are critical to success. #cardiogenicshock

[Jean-Luc Maigrot @JLmaigrotMD]

In our new review, we discuss considerations for patient-specific device tailoring in temporary mechanical circulatory support for cardiogenic shock, along with strategies to facilitate safe mobilization in appropriately selected patients. @AaronWeissMD
https://t.co/PpQFw1G7Et

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Longitudinal follow-up in the largest single-centre Heartmate 3 cohort to date characterizing the nuanced temporal patterns in risks of mortality and adverse events. #lvad #hm3 #heartfailure

[Jean-Luc Maigrot @JLmaigrotMD]

In 431 HM3 pts @CleClinicHVTI, long-term survival was favorable despite high acuity. Time-varying risks—early neuro events; later infections, GI bleeding, RHF—and rehospitalizations are areas for future improvement strategies. 🔗 https://t.co/TC3zbhuh5n

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Stratifying patients in shock receiving Impella 5.5 may help us understand future trajectories. However, even later stages of shock demonstrate acceptable outcomes in appropriately selected patients. Great job @JLmaigrot

[Jean-Luc Maigrot @JLmaigrotMD]

Our experience @CleClinicHVTI shows that preop SCAI stage in patients w/ Impella 5.5 is associated w/ survival on support & successful transition to LVAD/transplant. Preop triage may improve risk-benefit assessment and exit-strategy planning. https://t.co/TVm6U8z2cE

[Aaron J. Weiss, MD PhD @AaronWeissMD]

@JLmaigrot with another outstanding manuscript furthering our understanding of risk while on Impella support.

[AATS @AATSHQ]

New in mechanical circulatory support: Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support? Researchers from @CleClinicHVTI answer this in #JTCVS Open: https://t.co/28TivCGlEh

@AaronWeissMD @rcstarling @AndrewHigginsMD @David_Moros17

[Aaron J. Weiss, MD PhD @AaronWeissMD]

@JLmaigrot @David_Moros17 @MichaelTongMD @EdSolteszMD @LarsSvenssonMD @RanLeeMD @FaisalBakaeen Eugene Blackstone @ShinyaUnai_MD @EricRoselliMD

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Excited to share our experience with Impella in managing patients presenting with a post-MI VSR. Study highlights new insights in device use, hemodynamic benefits and improved outcomes within the scope of a shifting treatment paradigm. #jtcvs
https://t.co/6YWCn8UcfP

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Incredibly proud of the team here @CleClinicHVTI It is an honor to work among such amazing caregivers.

[Lars Svensson @LarsSvenssonMD]

It’s an honor to be recognized as the #1 hospital for heart care for the 30th consecutive year.

This is a testament to the commitment, talent and compassion of our @CleClinicHVTI team.

They’re dedicated to excellence in every aspect of their work.
https://t.co/ypmGsORd5i

[Aaron J. Weiss, MD PhD @AaronWeissMD]

@DJPBurns @BobbyYanagawa Best of luck @DJPBurns

[David Moros @David_Moros17]

#AATS2024 @AATSHQ in #Toronto 🇨🇦 has come to an end!

Grateful and honored for the opportunity to work in the @CleClinicHVTI #HeartFailure Research Lab with awesome mentors @AaronWeissMD @MichaelTongMD @EdSolteszMD @smedirn, and to present our teamwork @JLmaigrot🫀

@CCF_CTSRes

[Aaron J. Weiss, MD PhD @AaronWeissMD]

@JLmaigrot @AATSHQ @David_Moros17 @EdSolteszMD @MichaelTongMD @CleClinicHVTI @LarsSvenssonMD @FaisalBakaeen @EricRoselliMD @AskDrMarc

[Dominique Vervoort @DVervoort94]

Can we automate & contextualize literature reviews in #CTSurgery?

Dr. @karamlou et al @ClevelandClinic @IBM @SyracuseU introduce #SciScribe, which promises to save us all hundreds of hours spent on PubMed, Covidence, & other software to search, retrieve, collate info.

#AATS2024

[Aaron J. Weiss, MD PhD @AaronWeissMD]

@EdSolteszMD @MichaelTongMD @CleClinicNews @ClevelandClinic @CCF_CTSRes @AskDrMarc @FaisalBakaeen @EricRoselliMD @rcstarling @MariaMountis @karamlou @ShinyaUnai_MD @MdGosta @PatrickVargoMD @HElgharablyMD @DKimmaliardjuk @CCLRI

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Outstanding representation by the @CleClinicHVTI #heartfailure Research Lab translating the bench to the bedside @AATSHQ #AATS2024 to celebrate @LarsSvenssonMD presidency. Incredible teamwork and innovation. Special s/o to my all-🌟students @JLmaigrot & @David_Moros17

[Jean-Luc Maigrot @JLmaigrotMD]

Great weekend @AATSHQ #AATS2024 with 3 outstanding presentations from our CCF heart failure clinical research group @AaronWeissMD @David_Moros17 @EdSolteszMD @MichaelTongMD

All made possible by the incredible mentors and opportunities @CleClinicHVTI

[AATS @AATSHQ]

Presenting now and newly published in #JTCVS: Efficacy and Safety of a Transaortic Approach to Midventricular and Apical Septal Myectomy. Maigrot, Smedira, et al. https://t.co/IIUukrDoRN #AATS2024

@AaronWeissMD @David_Moros17

[David Moros @David_Moros17]

Read our article published simultaneously today in #JTCVS.

Fantastic work led by the all-start med student @JLmaigrot

🔗Link: https://t.co/fy9EfVmcCb

@AaronWeissMD #AATS2024 @AATSED @AATSHQ

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Having a fun time at #AATS2024 getting to share with everyone the great team work @CleClinicHVTI @ClevelandClinic under @LarsSvenssonMD leadership.

[David Moros @David_Moros17]

Outstanding presentation by @AaronWeissMD on the high-volume single-center experience and outcomes from @CleClinicHVTI with HeartMate3 implantation🫀

#AATS2024 @AATSHQ @MichaelTongMD @EdSolteszMD @ShinyaUnai_MD @JLmaigrot @CCF_CTSRes

[Daniel Ragheb @daniel_ragheb]

Equally impressive to all the work from the @CleClinicHVTI faculty is the work from current trainees (and my current role models) @CCF_CTSRes. Shoutout to my soon-to-be co-intern @MattThompsonMD for constantly adding to the field, absolute rockstar @ThoracicStudent @TSRA_official

[Aaron J. Weiss, MD PhD @AaronWeissMD]

Another fabulous presentation by @CleClinicHVTI research fellow Dr David Moros who argues for a paradigm shift in treating post MI VSRs with Impellas to facilitate non-emergency surgery. Wonderful job David on a tough topic. #AATS2024 @AATSHQ @ClevelandClinic @LarsSvenssonMD

[David Moros @David_Moros17]

Join me today at 5 PM in Room 718A for my oral presentation during the Advanced HF Innovations session, where I will discuss the paradigm shift in treating post-MI VSR🫀

@AaronWeissMD @MichaelTongMD @JLmaigrot @EdSolteszMD @smedirn @CleClinicHVTI @CCF_CTSRes

#AATS2024 @AATSHQ

[Faisal Bakaeen MD @FaisalBakaeen]

@jp_umana masterfully describes how to repair a giant coronary aneurysm @AATSHQ #AATS2024 @CleClinicHVTI @CleClinicHVTI

[David Moros @David_Moros17]

Join me today at 5 PM in Room 718A for my oral presentation during the Advanced HF Innovations session, where I will discuss the paradigm shift in treating post-MI VSR🫀

@AaronWeissMD @MichaelTongMD @JLmaigrot @EdSolteszMD @smedirn @CleClinicHVTI @CCF_CTSRes

#AATS2024 @AATSHQ